FDA Approves First Home Test for Three BRCA Breast Cancer Genes

TUESDAY, March 6, 2018 — The first consumer test for three BRCA gene mutations associated with breast, ovarian and prostate cancer risk has been approved by the U.S. Food and Drug Administration.
The three gene mutations are most common in people…
Source: Topamax